Gamida Cell: Positive Topline Data from Phase 3 Trial of Omidubicel in High-Risk Hematologic Malignancy Patients Requiring Marrow Transplant – CBI
Homepage /  Press Release /  Gamida Cell: Positive Topline Data from Phase 3 Trial of Omidubicel in High-Risk Hematologic Malignancy Patients Requiring Marrow Transplant

Press Release

Gamida Cell: Positive Topline Data from Phase 3 Trial of Omidubicel in High-Risk Hematologic Malignancy Patients Requiring Marrow Transplant